Literature DB >> 9887374

X-linked ocular albinism: prevalence and mutations--a national study.

T Rosenberg1, M Schwartz.   

Abstract

In a national retrospective register study 112 patients with ocular albinism (OA) were identified, including 60 male patients with proven or presumed X-linked ocular albinism (XLOA). Based on the birth year cohorts 1960-1989, an XLOA point prevalence at birth of 1 in 60,000 live-born was calculated. We identified 14 XLOA families in the Danish population, and obtained DNA from affected persons in nine families. Mutation analysis of the OA1 gene demonstrated seven presumed pathogenic mutations in the nine families with XLOA: five single nucleotide substitutions predicting a change of conserved amino acids (G35D, L39R, D78V, W133R and E233K) when compared with the mouse OA1 homologue, one deletion leading to the skipping of exon 2, and one single nucleotide substitution expected to affect the 5' splice site of intron 2 were found. Subsequent genealogical investigations in the three families harbouring the same mutation disclosed that two of the three pedigrees belonged to the same family. All mutations predict crucial changes in the protein structure. Clinical examination failed to identify any phenotype-genotype pattern except a milder phenotype devoid of iris translucency in the patient with the 5'splice site mutation of intron 2.

Entities:  

Mesh:

Year:  1998        PMID: 9887374     DOI: 10.1038/sj.ejhg.5200226

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  10 in total

1.  Abnormal crossing of the optic fibres shown by evoked magnetic fields in patients with ocular albinism with a novel mutation in the OA1 gene.

Authors:  L Lauronen; R Jalkanen; J Huttunen; E Carlsson; S Tuupanen; S Lindh; H Forsius; E-M Sankila; T Alitalo
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

Review 2.  Pigmentation and vision: Is GPR143 in control?

Authors:  Brian S McKay
Journal:  J Neurosci Res       Date:  2018-05-14       Impact factor: 4.164

3.  Clinical utility gene card for oculocutaneous (OCA) and ocular albinism (OA)-an update.

Authors:  Abdullah Aamir; Helen J Kuht; Karen Grønskov; Brian P Brooks; Mervyn G Thomas
Journal:  Eur J Hum Genet       Date:  2021-01-27       Impact factor: 5.351

4.  Deep intronic GPR143 mutation in a Japanese family with ocular albinism.

Authors:  Takuya Naruto; Nobuhiko Okamoto; Kiyoshi Masuda; Takao Endo; Yoshikazu Hatsukawa; Tomohiro Kohmoto; Issei Imoto
Journal:  Sci Rep       Date:  2015-06-10       Impact factor: 4.379

5.  GPR143 mutations in Chinese patients with ocular albinism type 1.

Authors:  Xiuhua Jia; Jin Yuan; Xiaoyun Jia; Shiqi Ling; Shiqiang Li; Xiangming Guo
Journal:  Mol Med Rep       Date:  2017-03-23       Impact factor: 2.952

6.  A novel GPR143 mutation in a Chinese family with X‑linked ocular albinism type 1.

Authors:  Xuhui Gao; Tiecheng Liu; Xuan Cheng; Aiai Dai; Wei Liu; Runpu Li; Maonian Zhang
Journal:  Mol Med Rep       Date:  2019-11-12       Impact factor: 2.952

7.  A novel nonsense mutation of the GPR143 gene identified in a Chinese pedigree with ocular albinism.

Authors:  Naihong Yan; Xuan Liao; Su-ping Cai; Changjun Lan; Yun Wang; Xiaomin Zhou; Yan Yin; Wenhan Yu; Xuyang Liu
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

8.  Identification of three novel OA1 gene mutations identified in three families misdiagnosed with congenital nystagmus and carrier status determination by real-time quantitative PCR assay.

Authors:  Valérie Faugère; Sylvie Tuffery-Giraud; Christian Hamel; Mireille Claustres
Journal:  BMC Genet       Date:  2003-01-07       Impact factor: 2.797

9.  Existing data sources for clinical epidemiology: Danish registries for studies of medical genetic diseases.

Authors:  Mary Nguyen-Nielsen; Elisabeth Svensson; Ida Vogel; Vera Ehrenstein; Lone Sunde
Journal:  Clin Epidemiol       Date:  2013-08-08       Impact factor: 4.790

10.  Simultaneous Expression of ABCA4 and GPR143 Mutations: A Complex Phenotypic Manifestation.

Authors:  Winston Lee; Kaspar Schuerch; Yajing Xie; Jana Zernant; Stephen H Tsang; Janet R Sparrow; Rando Allikmets
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-06-01       Impact factor: 4.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.